Crestor is part of a class of drugs called statins, which are used to help lower cholesterol levels in the blood. It is widely considered the most powerful statin on the market.
There has been a growing body of evidence which suggests that statins such as Crestor may lead to potentially serious side effects, particularly cardiomyopathy. As a result, many doctors are calling for clinical studies of Crestor and other statins to determine the extent to which these drugs may adversely impact the health of patients.
Crestor and Cardiomyopathy
Statins lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase. However, these drugs also have the unintended effect of depleting levels of Coenzyme Q10, which is important for ensuring proper heart function. As a result, patients taking Crestor and other statins face a substantially increased risk of developing cardiomyopathy, a disease affecting the functioning of the heart muscle.
Cardiomyopathy can result in an inability of the heart to effectively pump blood throughout the body, resulting in serious complications such as:
- Heart failure
- Abnormal heart rhythms
- Fluid buildup in the lungs or legs
- Inflammation of the heart lining
Pharmaceutical Companies Knew the Risks
There is considerable evidence that pharmaceutical manufacturers of statins have known about the risks associated with these drugs for a long time. However, they have consistently failed to provide adequate warnings of these risks, and they have failed to initiate the clinical studies necessary to accurately determine the extent of this risk. This lack of action on the part of pharmaceutical companies is grossly irresponsible, providing yet another example of an instance where profits has been placed above patient safety.
The Food and Drug Administration (FDA) has recently received a petition requesting that a "Black Box" label be placed on Crestor and other statins. This is the strongest warning that can be issued by the FDA, and it is only used in cases where drugs prose serious or life-threatening risks to consumers. It is uncertain how the FDA will respond to the petition.
Due to the failure of pharmaceutical companies to provide adequate warnings of the risks associated with Crestor and other statins, many individuals who have suffered cardiomyopathy from statin usage have been filing pharmaceutical injury claims against the drug companies in order to receive compensation for their medical bills and other damages. If you believe your cardiomyopathy was caused by taking Crestor or another statin drug, it is crucial that you consult an experienced pharmaceutical injury lawyer at once. There are important deadlines which must be met in order for you to successfully pursue your claim against the drug companies.
Please contact us today to find an experienced Crestor lawyer in your area.